BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 34357760)

  • 1. Hypoxia-Adapted Sono-chemodynamic Treatment of Orthotopic Pancreatic Carcinoma Using Copper Metal-Organic Frameworks Loaded with an Ultrasound-Induced Free Radical Initiator.
    Sun Y; Cao J; Wang X; Zhang C; Luo J; Zeng Y; Zhang C; Li Q; Zhang Y; Xu W; Zhang T; Huang P
    ACS Appl Mater Interfaces; 2021 Aug; 13(32):38114-38126. PubMed ID: 34357760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal-Organic Framework (MOF)-Based Ultrasound-Responsive Dual-Sonosensitizer Nanoplatform for Hypoxic Cancer Therapy.
    Zhang C; Xin L; Li J; Cao J; Sun Y; Wang X; Luo J; Zeng Y; Li Q; Zhang Y; Zhang T; Huang P
    Adv Healthc Mater; 2022 Jan; 11(2):e2101946. PubMed ID: 34706160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cancer therapy by hypoxia-responsive copper metal-organic frameworks nanosystem.
    Zhang K; Meng X; Yang Z; Dong H; Zhang X
    Biomaterials; 2020 Nov; 258():120278. PubMed ID: 32781328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NIR-II-driven and glutathione depletion-enhanced hypoxia-irrelevant free radical nanogenerator for combined cancer therapy.
    Zhang L; Fan Y; Yang Z; Yang M; Wong CY
    J Nanobiotechnology; 2021 Sep; 19(1):265. PubMed ID: 34488803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic nucleus-targeted ultra-small metal-organic framework for the type I sonodynamic treatment of orthotopic pancreatic carcinoma.
    Zhang T; Sun Y; Cao J; Luo J; Wang J; Jiang Z; Huang P
    J Nanobiotechnology; 2021 Oct; 19(1):315. PubMed ID: 34641905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
    Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
    Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-responsive and NIR-driven free radical nanoamplifier with glutathione depletion for enhanced tumor-specific photothermal/thermodynamic/chemodynamic synergistic Therapy.
    Chen F; Zhang X; Wang Z; Xu C; Hu J; Liu L; Zhou J; Sun B
    Biomater Sci; 2022 Oct; 10(20):5912-5924. PubMed ID: 36040793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conferring Ti-Based MOFs with Defects for Enhanced Sonodynamic Cancer Therapy.
    Liang S; Xiao X; Bai L; Liu B; Yuan M; Ma P; Pang M; Cheng Z; Lin J
    Adv Mater; 2021 May; 33(18):e2100333. PubMed ID: 33792083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acidic TME-Responsive Nano-Bi
    Li Y; Yu H; Ren J; Lu G; Cao Y; Xu Z; Kang Y; Xue P
    Small; 2022 Jan; 18(2):e2104302. PubMed ID: 34761867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional nanoparticles for enhanced sonodynamic-chemodynamic immunotherapy with glutathione depletion.
    Song J; Tang C; Wang Y; Ba J; Liu K; Gao J; Chang J; Kang J; Yin L
    Nanomedicine (Lond); 2024 Jan; 19(2):145-161. PubMed ID: 38270976
    [No Abstract]   [Full Text] [Related]  

  • 11. A Cu-based nanoplatform for near-infrared light amplified multi-mode prostate cancer specific therapy.
    Xu B; Niu R; Tang Y; Wang C; Jin L; Wang Y
    J Mater Chem B; 2022 Sep; 10(37):7628-7633. PubMed ID: 35894661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable Biomimic Copper/Manganese Silicate Nanospheres for Chemodynamic/Photodynamic Synergistic Therapy with Simultaneous Glutathione Depletion and Hypoxia Relief.
    Liu C; Wang D; Zhang S; Cheng Y; Yang F; Xing Y; Xu T; Dong H; Zhang X
    ACS Nano; 2019 Apr; 13(4):4267-4277. PubMed ID: 30901515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy.
    Wang Z; Liu B; Sun Q; Dong S; Kuang Y; Dong Y; He F; Gai S; Yang P
    ACS Appl Mater Interfaces; 2020 Apr; 12(15):17254-17267. PubMed ID: 32227859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tablet-like TiO
    Cao J; Sun Y; Zhang C; Wang X; Zeng Y; Zhang T; Huang P
    Acta Biomater; 2021 Jul; 129():269-279. PubMed ID: 34082101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of triple negative breast cancer by near infrared light triggered mild-temperature photothermal therapy combined with oxygen-independent cytotoxic free radicals.
    Li R; Hu X; Shang F; Wu W; Zhang H; Wang Y; Pan J; Shi S; Dong C
    Acta Biomater; 2022 Aug; 148():218-229. PubMed ID: 35705171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemodynamic therapy agent optimized mesoporous TiO
    Chen J; Zhang J; Wei X; Zhang Y; Hu J; Liu H; Zhang S; Yang B
    J Colloid Interface Sci; 2023 Nov; 650(Pt B):1773-1785. PubMed ID: 37506418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urchin-Shaped Metal Organic/Hydrogen-Bonded Framework Nanocomposite as a Multifunctional Nanoreactor for Catalysis-Enhanced Synergetic Therapy.
    Hu C; Wang J; Liu S; Cai L; Zhou Y; Liu X; Wang M; Liu Z; Pang M
    ACS Appl Mater Interfaces; 2021 Feb; 13(4):4825-4834. PubMed ID: 33496168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoarchitectonics with metal-organic frameworks and platinum nanozymes with improved oxygen evolution for enhanced sonodynamic/chemo-therapy.
    Ren Q; Yu N; Wang L; Wen M; Geng P; Jiang Q; Li M; Chen Z
    J Colloid Interface Sci; 2022 May; 614():147-159. PubMed ID: 35091144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential Ultrasound-Triggered and Hypoxia-Sensitive Nanoprodrug for Cascade Amplification of Sonochemotherapy.
    Zhuang F; Ma Q; Dong C; Xiang H; Shen Y; Sun P; Li C; Chen Y; Lu B; Chen Y; Huang B
    ACS Nano; 2022 Apr; 16(4):5439-5453. PubMed ID: 35357810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering defected 2D Pd/H-TiO
    Qiao X; Xue L; Huang H; Dai X; Chen Y; Ding H
    J Nanobiotechnology; 2022 Apr; 20(1):186. PubMed ID: 35413839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.